# Vaccine and Treatment Evaluation Units: Wolbachia-Infected Aedes aegypti Mosquitos in Reducing Arboviral Infection Brazil

> **NIH NIH N01** · EMORY UNIVERSITY · 2020 · $7,999,643

## Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations  is also available.

## Key facts

- **NIH application ID:** 10115327
- **Project number:** 272201300018I-0-759302000001-1
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** NADINE ROUPHAEL
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $7,999,643
- **Award type:** —
- **Project period:** 2020-02-04 → 2024-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10115327

## Citation

> US National Institutes of Health, RePORTER application 10115327, Vaccine and Treatment Evaluation Units: Wolbachia-Infected Aedes aegypti Mosquitos in Reducing Arboviral Infection Brazil (272201300018I-0-759302000001-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10115327. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*